Zoledronic acid in the management of metastatic bone disease.
about
Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literatureSamarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.Painful boney metastases.Dose-Fractionation Schedules for Radiotherapy of Bone Metastases.Bone Pain and Muscle Weakness in Cancer Patients.Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review.Bisphosphonate anticancer activity.Bisphosphonate conjugation for bone specific drug targeting.
P2860
Q34696283-FAD37221-8DBD-4E21-948E-55BCE2883B6EQ37004657-D1CAAB29-41F7-4D9F-846D-9DED1F2F654DQ37011060-361D79EF-141F-46DA-BE0F-9AD5BCE44195Q37903673-49DCF5BB-7401-4E0E-AC06-B892C7DD84BFQ38684768-BFBFF610-AA62-4936-B1CB-01220A2D1DE0Q38979535-A859E671-7BCF-47A7-AB54-8C6109111C83Q53289373-0E775C46-D23D-4C94-8BCF-3B49FC6024F8Q55515922-E3DBF91D-9E35-46CC-B610-A4E4BB477B92
P2860
Zoledronic acid in the management of metastatic bone disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Zoledronic acid in the management of metastatic bone disease.
@ast
Zoledronic acid in the management of metastatic bone disease.
@en
type
label
Zoledronic acid in the management of metastatic bone disease.
@ast
Zoledronic acid in the management of metastatic bone disease.
@en
prefLabel
Zoledronic acid in the management of metastatic bone disease.
@ast
Zoledronic acid in the management of metastatic bone disease.
@en
P2860
P50
P1476
Zoledronic acid in the management of metastatic bone disease
@en
P2093
Maria Elisabetta Fratto
Sara Galluzzo
P2860
P304
P356
10.1517/14712598.6.12.1333
P407
P577
2006-12-01T00:00:00Z